Scott Kellen - Jun 1, 2025 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
CFO & Secretary
Signature
/s/ Scott Kellen
Stock symbol
DMAC
Transactions as of
Jun 1, 2025
Transactions value $
$0
Form type
4
Date filed
6/3/2025, 04:16 PM
Previous filing
Jun 3, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kellen Scott CFO & Secretary 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS /s/ Scott Kellen 2025-06-03 0001490476

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DMAC Voting Common Shares, no par value per share 32.3K Jun 1, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DMAC Stock Option (right to buy) Award $0 +225K $0.00 225K Jun 1, 2025 Common Shares 225K $4.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026.